Navigation Links
Symposium focuses on curable cancer that affects young men
Date:5/14/2008

The latest information on the biology and treatment of testicular cancer, the most common cancer among young men, will be presented at the Symposium on Testicular Cancer organized by the European Society for Medical Oncology (ESMO), to be held on 15-16 May in Munich, Germany.

"Testicular cancer is the most common tumor in men between the ages of eighteen and thirty-five and has seen the strongest increase in incidence among all cancer types over the last 20 years," said the Symposium's Scientific Chair Prof. Hans-Joachim Schmoll, Director of the Department of Internal Medicine for oncology and hematology at the Martin Luther University Halle and former president of the German association for medical oncology (AIO).

Currently, testicular cancer affects one in every 100 men per year in Europe. The causes of the dramatic rise in incidence remain unclear.

The cure rate for testicular cancer has increased dramatically in recent years, thanks to improvements in chemotherapy. As a result, the treatment strategies in virtually all stages of the disease have changed, away from aggressive surgical or radiation treatment to surveillance without treatment or minimal treatment for most patients in early stages and only limited chemotherapy in advanced stages.

"All these changes in treatment approach mean patients need highly informed and experienced doctors, both to give them the best advice on selecting optimal treatment and then to implement with expertise the adopted course," Prof. Schmoll continued.

The ESMO Symposium on Testicular Cancer will present cutting-edge information on the molecular background of testicular cancer. Sessions will focus on explaining the sensitivity of this tumor to chemotherapy, on prognostic factors and on practical decision-making options for individual patients. In particular, treatment options will be discussed against the background of the European Consensus Guidelines.

After the public
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
0041-919-731-907
European Society for Medical Oncology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. 2nd ESMO symposium on soft tissue carcinomas and GIST
2. Smart Balance to Webcast Presentation at Goldman Sachs Consumer Products Symposium
3. Aflac CEO Funds Breast Cancer Symposium in Honor of Companys African-American Female Employees
4. Symposium Targets Critical Manufacturing Topics for Emerging Growth Companies
5. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
6. ATS Medical Announces First Frontiers in Cryoablation Symposium
7. Stem Cells(R) and International Stem Cell Symposium Present Annual Stem Cells(R) Young Investigator Award
8. Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
9. 5W Public Relations Presents the 2008 Body Beautiful Media Symposium Benefiting The Skin Cancer Foundation
10. Symposium to explore role nanoparticles may play in disease
11. NARSADs 5th Annual Mission Possible Symposium Offers Insight to PTSD and Other Mental Illnesses

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...KELOWNA,BC,Nov.27/PRNewswire/-UploadableUSBpedomet...ness.Acombinationofadvancedaccelerometerfunctional...novertheaccuracyofself-reporteddata.It,snowpossibl...afitnessprogram. ,, CoreHealthTechnologiesisone...gy."Ourhealthchallengesareeasytoadministerandparti...
(Date:11/27/2009)...SANFRANCISCO,Nov.27/PRNewswire-FirstCall/--TheGymb...mbert,CFO/COO,willpresentattheNASDAQOMX23rdInvesto...England,onWednesday,December2,2009,at11:45a.m.GMT....ation,spresentationovertheInternet,pleaselogontoww...page,goto"InvestorandMediaRelations"andthen"Confer...
(Date:11/27/2009)...KIBBUTZSHAMIR,Israel,Nov.27/PRNewswire-FirstCall/-..." ),aleadingproviderofinnovativeproductsandtechnol...boardofdirectorshaddeclaredadividenddistributionin....62millionbasedontheNovember25,2009representativer...lyNIS2.3basedontheNovember25,2009representativerat...
(Date:11/27/2009)...rates to bring unprecedented medical, economic bur... (HealthDay News) -- The number of people with dia...ver the next 25 years, a new study predicts. , ...illion people with the disease, up from 23.7 milli...ting people with diabetes will triple, the study a...
(Date:11/27/2009)... Multi-purpose bilingual coloring...d for use by the business community to educate - i...ubjects from Safety issues to Dinosuars to ABC,S a... Saint Louis, MO (PRWEB) November 27, 2009 -- T...nics or toys to keep them busy any hour of the day...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...e officer for Aboriginal Medical Services Alliance...nal communities could be provided// better access ...on over the Internet if funds of $1 million are gr... medical practices and health centres who adopt br...
...ts during pregnancy may lead to various health com... E is an anti-oxidant found naturally in foods lik...ch had suggested that vitamin E, particularly take...ital in London, warned that pregnant women could b...
... it was found that researchers at the UC Davis Can...ce of amino acids // . The speciality of this disc...finity, stability and specificity towards leukemic...ublished in the journal Nature Chemical Biology. ‘...
...abetes, one of the world’s leading debilitating di...It affects an estimated 194 million adults worldwi...ve and effective therapeutic options that are bene...the cases. This type is the direct result of the b...
... seizures, or psychogenic seizures are often misdi...ed by psychological condition //whereas epilepsy i...e brain. Because these nonepileptic seizure...ntific journal of the American Academy of Neurolog...
...e chips have been used by a pediatric research tea...order to identify small defects that lead to gene...c tests usually cannot detect these abnormalities,... years, many children who have multiple congenital...
Other Medicine News:Health News:New Molecular Treatment Identified To Treat Blood Cell Cancers 2Health News:Inhaled Insulin: A New Modality for Management of Diabetes 2Health News:Clues To Identify Psychological Seizures 2Health News:Clues To Identify Psychological Seizures 3Health News:Hunt for Chromosomal Errors Which Cause Genetic Diseases 2Health News:Hunt for Chromosomal Errors Which Cause Genetic Diseases 3Health News:Hunt for Chromosomal Errors Which Cause Genetic Diseases 4
(Date:11/25/2009)...PRNewswire-FirstCall/--Hologic,Inc.(HologicortheCo...erandsupplierofpremiumdiagnostics,medicalimagingsy...hcareneedsofwomen,isusingtheannualmeetingoftheRadi...einChicago,November29throughDecember3,2009tohighli...cmammographyworkstationsoftware. ,, TheHologicS...
(Date:11/25/2009)...25/PRNewswire/--TheFDAgrantedtraditionalapprovalfo...ereversetranscriptaseinhibitor(NNRTI).INTELENCEist...experiencedadultswhoareexperiencingvirologicfailur...roviral(ARV)agents.Thetraditionalapprovalisbasedon...T-2.INTELENCEiscurrentlymarketedintheU.S.byTibotec...
(Date:11/25/2009)...RNewswire-Asia-FirstCall/--ChinaSkyOne,Medical,Inc... ),a,leadingfullyintegratedpharmaceuticalcompanyde...ple,sRepublicofChina("PRC"),today,announcedthatthe...r,theControlofPharmaceuticalandBiologicalProducts(...nosticKitforHumanProstateSpecific,Antigen(Colloida...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Study aims to induce recovery from ankylosing spondylitis 52298 1Study aims to induce recovery from ankylosing spondylitis 52298 2Tires made from trees better cheaper more fuel efficient 9304 1Tires made from trees better cheaper more fuel efficient 9304 2Preimplantation genetic diagnosis may pose neurological risks 9300 1Preimplantation genetic diagnosis may pose neurological risks 9300 2
...ted the Clinical Potential of Peregrine,s,Unique S...tive as,Avastin(R) in Animal Cancer Models, TUSTIN...,Peregrine Pharmaceuticals, Inc. , a clinical stag...noclonal antibodies,for the treatment of cancer an... data from multiple studies presented at the recen...
...SS WIRE)--Apr 23, 2007 - Affitech AS, the,human an...eregrine,Pharmaceuticals, Inc. reported positive i...l antibody developed by Affitech, in a,pancreatic ...Annual,Meeting of the American Association for Can...wo companies for selective blocking of,VEGF (vascu...
Other Medicine Technology:Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 2Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 3Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 4Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 5Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 6Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 7Positive Results Using Affitech-Identified Human Antibody That,Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model,Reported by Peregrine 2
ABX Pentra 80
...is an easy-to-use, workflow-based system designed ...ex consists of the SleepWorks software and either ...rable systems can be used for a complete range of ...g full EEG recording - and have superior signal qu...
...d-alone microprocessor-controlled photometer desig...ell microplates using single- or dual- wavelength ...velength) and a dynamic reading range up to 4.0 OD...ry or assay requirements. Self-diagnostics (up to ...
Variant II Total GHb Program
Medicine Products: